Navigation Links
FDA Warns Against Use of Diarrhea Drug From El Salvador
Date:9/19/2012

WEDNESDAY, Sept. 19 (HealthDay News) -- Consumers should not use a drug product called Intestinomicina -- marketed as a treatment for infectious diarrhea and acute gastrointestinal infections -- because it contains an ingredient that can cause serious and potentially deadly problems, the U.S. Food and Drug Administration warns.

People who bought Intestinomicina should immediately stop taking it and consult with a health care provider, the FDA said in a safety alert issued Tuesday.

Intestinomicina, which is made in El Salvador, contains a prescription drug ingredient called chloramphenicol. Earlier this year, in July, oral forms of chloramphenicol were taken off the U.S. market due to the risk of serious health problems.

The most dangerous threat associated with oral chloramphenicol is bone marrow toxicity, which occurs when the body does not produce enough red blood cells, white blood cells and/or platelets, the FDA noted in a news release.

While some types of bone marrow toxicity are reversible, in certain rare cases it can lead to death. Those at greatest risk for serious injury or death are patients with anemia, low white or red blood cell count, or decreased blood platelets.

Intestinomicina's label also lists antibacterial ingredients including neomycin, which is an antibiotic often found in topical medications, and sulfonamides (sulfa drugs). Neomycin and sulfa drugs can cause a variety of reactions, ranging from rashes and hives to severe and life-threatening reactions, the FDA said.

In addition, Intestinomicina may interact with other medications people may be taking, the FDA pointed out in the news release.

Intestinomicina -- made by Laboratorios Lopez -- is sold in tablet and liquid form by international grocery stores in the United States that feature South and Central American specialty foods and products.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diarrhea and its treatment.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, Sept. 18, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dont cut lifesaving ICDs during financial crisis, ESC warns
2. US risks losing out to Asia in medical research, U-M team warns
3. Extreme Heat Biggest Weather Killer, Expert Warns
4. CDC Warns of Another Emerging Tick-Borne Threat
5. The US Drug Watchdog Now Warns Time Could Run Out to Get Women Yaz or Yasmin Birth Control Pill Users Identified if they Suffered a Heart Attack Stroke or a Embolism
6. New device warns workers of high levels of airborne metals in minutes rather than weeks
7. FDA Warns of Fake Version of ADHD Drug Adderall
8. Immigrant women giving birth in Spain suffer great stress, a study warns
9. Vall d’Hebron, VHIO and SOLTI head up an international dream team against breast cancer
10. New gene offers hope for preventive medicine against fractures
11. Drug combination against NRAS-mutant melanoma discovered
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Warns Against Use of Diarrhea Drug From El Salvador 
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
Breaking Medicine Technology: